Alpha-lipoic acid: Antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy

Free Radical Biology and Medicine

Volumn 21, Issue 5, 1996, Pages 631-639

  Nickander, Kim K ^a   McPhee, Benjamin R ^a   Low, Phillip A ^a   Tritschler, Hans ^b  

^a MAYO CLINIC   (United States)

^b ASTA MEDICA AG   (Germany)

Author keywords

Diabetes; Free radicals; Neuropathy; Lipoic acid

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; EDETIC ACID; FERROUS ASCORBATE; FREE RADICAL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOCTIC ACID;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; HYPOXEMIA; ISCHEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

ANIMALIA;

EID: 0029764551     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(96)00172-4     Document Type: Article

References (57)

1. 1. Wolff, S. P.; Jiang, Z. Y.; Hunt, J. V. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic. Biol. Med. 10:339-352; 1991.
2. 2. Low, P. A.; Lagerlund, T. D.; McManis, P. G. Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Int. Rev. Neurobiol. 31:355-438; 1989.
3. 3. Tuck, R. R.; Schmelzer, J. D.; Low, P. A. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107:935-950; 1984.
4. 4. Low, P. A.; Nickander, K. K. Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 40:873-877; 1991.
5. 5. Nickander, K. K.; Schmelzer, J. D.; Rohwer, D. A.; Low, P. A. Effect of α-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve. J. Neurol. Sci. 126:6-14; 1994.
6. 6. Cameron, N. E.; Cotter, M. A.; Maxfield, E. K. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 36:299-304; 1993.
7. 7. Kalyanaraman, B.; Darley-Usmar, V. M.; Wood, J.; Joseph, J.; Parthasarathy, S. Synergistic interaction between the probucol phenoxyl radical and ascorbic acid in inhibiting the oxidation of low density lipoprotein. J. Biol. Chem. 267:6789-6795; 1992.
8. 8. Cameron, N. E.; Cotter, M. A.; Archibald, V.; Dines, K. C.; Maxfield, E. K. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in nondiabetic and streptozotocin-diabetic rats. Diabetologia 37:449-459; 1994.
9. 9. Karasu, C.; Dewhurst, M.; Stevens, E. J.; Tomlinson, D. R. Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; Comparison with essential fatty acids. Diabetologia 38:129-134; 1995.
10. 10. Bravenboer, B.; Rappelle, A. C.; Hamers, F. P. T.; van Buren, T.; Erkelens, D. W.; Gispen, W. H. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia 35:813-817; 1992.
11. 11. Cotter, M. A.; Cameron, N. E. Correction of impaired sciatic nerve perfusion by desferrioxamine in diabetic rats. Diabetologia 38(Suppl. 1):898; 1995.
12. 12. Busse, E.; Zimmer, G.; Schopohl, B.; Kornhuber, B. Influence of α-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschng Drug Res. 42:829-831; 1992.
13. 13. Dimpfel, W.; Spuler, M.; Pierau, F.-K.; Ulrich, H. Thioctic acid induces dose-dependent sprouting of neurites in cultured rat neuroblastoma cells. Dev. Pharmacol. Ther. 14:193-199; 1990.
14. 14. Nagamatsu, M.; Nickander, K. K.; Schmelzer, J. D.; Raya, A.; Wittrock, D. A.; Tritschler, H.; Low, P. A. Lipoic acid improves nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18:1160-1167; 1995.
15. 15. Kagan, V. E.; Shvedova, A.; Serbiniva, E.; Khan, S.; Swanson, C.; Powell, R.; Packer, L. Dihydrolipoic acid - A universal antioxidant both in the membrane and in the aqueous phase. Biochem. Pharmacol 44:1637-1649; 1992.
16. 16. Bast, A.; Haenen, G. R. Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. Biochim. Biophys. Acta 963:558-561; 1988.
17. 17. Haugaard, N.; Haugaard, E. S. Stimulation of glucose utilization by thioctic acid in rat diaphragm incubated in vitro. Biochim. Biophys. Acta 222:583-586; 1970.
18. 18. Bashan, N.; Burdett, E.; Klip, A. Effect of thioctic acid on glucose transport. 3rd Int. Thioctic Acid Workshop 3:218-223; 1993.
19. 19. Murase, K.; Hattori, A.; Kohno, M.; Hayashi, K. Stimulation of nerve growth factor synthesis/secretion in mouse astroglial cells by coenzymes. Biochem. Mol. Biol. Int. 30:615-621; 1993.
20. 20. Kemplay, S.; Martin, P.; Wilson, S. The effects of thioctic acid on motor nerve terminals in acrylamide-poisoned rats. Neuropathol. Appl. Neurobiol. 14:275-288; 1988.
21. 21. Cohen, G. The Fenton reaction. In: Greenwald, R. A. ed. Handbook of methods for oxygen radical research. Boca Raton, FL: CRC Press; 1985:55-64.
22. 22. Buege, J. A.; Aust, S. D. Microsomal lipid peroxidation. Methods Enzymol. 52:302-310; 1978.
23. 23. Ikenoya, S.; Takada, M.; Yuzuriha, T.; Abe, K.; Katayama, K. Studies on reduced and oxidized ubiquinones. I. Simultaneous determination of reduced and oxidized ubiquinones in tissues and mitochondria by high performance liquid chromatography. Chem. Pharm. Bull. 29:158-164; 1981.
24. 24. Lowry, O. H.; Rosebrough, N. J.; Fair, A. L.; Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275; 1951.
25. 25. O'Brien, P. C. The appropriateness of analysis of variance and multiple-comparison procedures. Biometrics 39:787-794; 1983.
26. 26. Podda, M.; Tritschler, H. J.; Ulrich, H.; Packer, L. α-Lipoic acid supplementation prevents symptoms of vitamin E deficiency. Biochem. Biophys. Res. Commun. 204:98-104; 1994.
27. 27. McCord, J. M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312:159-163; 1985.
28. 28. Halliwell, B.; Gutteridge, J. M. Free radicals in biology and medicine. Oxford: Clarendon Press; 1985.
29. 29. Hermenegildo, C.; Raya, A.; Roma, J.; Romero, F. J. Decreased glutathione peroxidase activity in sciatic nerve of alloxan-induced diabetic mice and its correlation with blood glucose levels. Neurochem. Res. 18:893-896; 1993.
30. 30. Jennings, P. E.; Chirico, S.; Lunec, J.; Barnett, A. H. Vitamin C metabolites and microangiopathy in diabetes mellitus. Diabetes Res. 6:151-154; 1987.
31. 31. Som, S.; Basu, D.; Mukherjee, S.; Deb, S.; Choudary, P. R.; Mukherjee, S. N.; Chatterjee, S. N.; Chatterjee, J. E. Ascorbic acid metabolism in diabetes mellitus. Metabolism 30:572-577; 1981.
32. 32. Yao, J. K.; Low, P. A. Improvement of endoneurial lipid abnormalities in experimental diabetic neuropathy by oxygen modification. Brain Res. 362:362-365; 1986.
33. 33. Low, P. A.; Ward, K.; Schmelzer, J. D.; Brimijoin, S. Ischemic conduction failure and energy metabolism in experimental diabetic neuropathy. Am. J. Physiol. 248:E457-E462; 1985.
34. 34. Ward, K. K.; Low, P. A.; Schmelzer, J. D.; Zochodne, D. W. Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain 112:197-208; 1989.
35. 35. Baynes, J. W. Role of oxidative stress in the development of complications in diabetes. Diabetes 40:405-412; 1991.
36. 36. Suzuki, Y. J.; Tsuchiya, M.; Packer, L. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic. Res. Commun. 15:255-263; 1991.
37. 37. Scott, B. C.; Aruoma, O. I.; Evans, P. J.; O'Neill, C.; van der Vliet, A.; Cross, C. E.; Tritschler, H.; Halliwell, B. Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. Free Radic. Res. 20:119-133; 1994.
38. 38. Handelman, G. J.; Han, D.; Tritschler, H.; Packer, L. Alpha-lipoic acid reduction by mammalian cells to the dithiol form, and release into the culture medium. Biochem. Pharmacol. 47:1725-1730; 1994.
39. 2+ in solution. Arch. Biochem. Biophys. 187:208-214; 1978.
40. 40. Grunert, R. The effect of D,L-α-lipoic acid on heavy metal intoxication in mice and dogs. Arch. Biochem. Biophys. 86:190-195; 1960.
41. 41. Matsugo, S.; Yan, L. J.; Han, D.; Tritschler, H. J.; Packer, L. Elucidation of antioxidant activity of alpha-lipoic acid toward hydroxyl radical. Biochem. Biophys. Res. Commun. 208:161-167; 1995.
42. 42. Pick, U.; Haramaki, N.; Constantinescu, A.; Handelman, C. J.; Tritschler, H. J.; Packer, L. Glutathione reductase and lipoamide dehydrogenase have opposite stereospecificities for alpha-lipoic acid enantiomers. Biochem. Biophys. Res. Commun. 206:724-730; 1995.
43. 43. Scholich, H.; Murphy, M. E.; Sies, H. Antioxidant activity of dihydrolipoate against microsomal lipid peroxidation and its dependence on alpha-tocopherol. Biochim. Biophys. Acta 1001:256-261; 1989.
44. 44. Packer, L. New horizons in antioxidant research: Action of the thioctic acid/dihydrolipoic acid couple in biological systems. In: Schmidt, K.; Ulrich, H. eds. Second international thioctic acid workshop. Frankfurt: Universimed Verlag; 1992:35-45.
45. 45. Maitra, I.; Serbinova, E.; Tritschler, H.; Packer, L. Alpha-lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats. Free Radic. Biol. Med. 18:823-829; 1995.
46. 46. Wagh, S. S.; Natraj, C. V.; Menon, K. K. G. Mode of action of lipoic acid in diabetes. J. Biosci. 11:59-74; 1987.
47. 47. Natraj, C. V.; Gandhi, V. M.; Menon, K. K. G. Lipoic acid and diabetes: Effect of dihydrolipoic acid administration in diabetic rats and rabbits. J. Biosci. 6:37-46; 1984.
48. 48. Ou, P.; Tritschler, H. J.; Wolff, S. P. Thioctic (lipoic) acid: A therapeutic metal-chelating antioxidant? Biochem. Pharmacol. 50:123-126; 1995.
49. 49. Vlassara, H.; Brownlee, M.; Cerami, A. Nonenzymatic glycosylation: Role in the pathogenesis of diabetic complications. Clin. Chem. 32:B37-B41; 1986.
50. 50. Brownlee, M.; Cerami, A.; Vlassara, H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318:1315-1321; 1988.
51. 51. Low, P. A.; Tuck, R. R.; Dyck, P. J.; Schmelzer, J. D.; Yao, J. K. Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. Proc. Natl. Acad. Sci. USA 81:6894-6898; 1984.
52. 52. Horrobin, D. Omega-6 essential fatty acids. New York: Liss; 1990.
53. 53. Horrobin, D. F. The use of gamma-linolenic acid in diabetic neuropathy. Agents Actions Suppl. 37:120-144; 1992.
54. 54. Carreau, J. P.; Lapous, D.; Raulin, J. Significance of essential fatty acids in intermediary metabolism. Hypothesis on the synthesis of lipoic acid. Biochimie 59:487-496; 1977.
55. 55. Ekstrom, P. A. R.; Kanje, M.; Skottner, A. Nerve regeneration and serum levels of insulin-like growth factor-1 in rats with streptozotocin-induced insulin deficiency. Brain Res. 496:141-147; 1989.
56. 56. Fernyhough, P.; Diemel, L. T.; Brewster, W. J.; Tomlinson, D. R. Deficits of nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: Effects of insulin treatment. Neuroscience 62:337-344; 1994.
57. 57. Westfall, S. G.; Felten, D. L.; Mandelbaum, J. A.; Moore, S. Q.; Petersen, R. G. Degenerative neuropathy in insulin-treated diabetic rats. J. Neurol. Sci. 61:93-107; 1983.